why choose us

Clinical Trials Search

Showing 12,290 of 132,366 result(s)
A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants.

Status: ACTIVE_NOT_RECRUITING

Condition: Healthy

Interventions: 6 capsules administered Q12 hours for 5 doses

Date: 2023-05-09

Effects of Altered Auditory Feedback on Speech Fluency

Status: Completed

Condition: Stuttering, Adult

Interventions: Mumble Melody is an application that leverages Altered Auditory Feedback (AAF).
During AAF, a person's speech is altered in near-real time.<

Date: 2023-05-09

Instantaneous EEG Changes Following Chiropractic Adjustment or Sham

Status: ACTIVE_NOT_RECRUITING

Condition: Subluxation

Interventions: Instrument-assisted, high velocity, low amplitude adjustment

Date: 2023-05-09

A Combination Study of CAR-T Therapy in r;r B-NHL

Status: Completed

Condition: Diffuse Large B Cell Lymphoma

Interventions: Intervention were given during bridging therapy and maintanance treament of CAR-T cell therpay.

Date: 2023-05-09

Assessment of the Rate of Oseointegration Surrounding Nano-coated Orthodontic Titanium Miniscrew

Status: COMPLETED

Condition: Health Care Utilization

Interventions: include six orthodontic patients, which have a surgical procedure to install two orthodontic titanium miniscrews in the two lateral parts of the maxil

Date: 2023-05-09

Tools for Anxiety and Depression Screening in Epilepsy

Status: Completed

Condition: Epilepsy

Interventions: Standard care screening questionnaires on anxiety and depression

Date: 2023-05-09

Two Fraction Prostate SBRT With DIL SIB

Status: Completed

Condition: Prostate Cancer

Interventions: Two-fraction SBRT with an MRI directed, dominant intraprostatic lesion, simultaneous integrated boost (SIB) based on genomic classification in the tre

Date: 2023-05-09

A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia

Status: Completed

Condition: Oropharyngeal Dysplasia

Interventions: Participants will take 200mg (2 x 100mg pastilles) of APG-157 therapy orally (PO) three times daily during each 4-week cycle for up to three cycles.

Date: 2023-05-09

Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR)

Status: Completed

Condition: Leber Congenital Amaurosis

Interventions: Low dose Medium dose High dose

Date: 2023-05-09

Reducing Self-stigma Using Brief Video Intervention

Status: COMPLETED

Condition: Stigma, Social

Interventions: A brief (119 seconds) social contact-based video.
The video presented a young Black man in his early twenties, a professional actor, sharing his

Date: 2023-05-09